Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study

被引：0
|
作者：
Calabrese, Joseph [1 ]
Sanchez, Raymond [1 ]
Jin, Na [1 ]
Amatniek, Joan [1 ]
Cox, Kevin [1 ]
Johnson, Brian [1 ]
Perry, Pamela P. [1 ]
Hertel, Peter [1 ]
Such, Pedro [1 ]
Salzman, Phyllis M. [1 ]
McQuade, Robert D. [1 ]
Nyilas, Margaretta [1 ]
Carson, William H. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2016年 / 41卷
关键词：
Bipolar I Disorder; Aripiprazole Once-Monthly; Maintenance Treatment; Long-Acting Injectable Antipsychotic;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T116
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
    Vieta, Eduard
    Montgomery, Stuart
    Sulaiman, Ahmad Hatim
    Cordoba, Rodrigo
    Huberlant, Benedicte
    Martinez, Lupe
    Schreiner, Andreas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (11) : 825 - 835
  • [32] Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]
    Seyed Mohammad Assadi
    Reza Radgoodarzi
    Seyed Ali Ahmadi-Abhari
    BMC Psychiatry, 3
  • [33] Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study
    Sachs, Gary
    Sanchez, Raymond
    Marcus, Ronald
    Stock, Elyse
    McQuade, Robert
    Carson, William
    Abou-Gharbia, Neveen
    Impellizzeri, Cheryl
    Kaplita, Stephen
    Rollin, Linda
    Iwamoto, Taro
    JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (04) : 536 - 546
  • [34] Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Durgam, Suresh
    Chen, Changzheng
    Migliore, Raffaele
    Prakash, Chandran
    Thase, Michael E.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 225 - 234
  • [35] Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study
    Marcus, Ronald
    Khan, Arif
    Rollin, Linda
    Morris, Beth
    Timko, Karen
    Carson, William
    Sanchez, Raymond
    BIPOLAR DISORDERS, 2011, 13 (02) : 133 - 144
  • [36] Effect of Lurasidone Dose on Recurrence Prevention in Patients With Bipolar I Disorder: Post Hoc Analysis of a Placebo-Controlled Randomized Withdrawal Study
    Frye, Mark
    Tsai, Joyce
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S525 - S526
  • [37] Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial
    Palacio, M.
    Cobo, T.
    Antolin, E.
    Ramirez, M.
    Cabrera, F.
    Mozo de Rosales, F.
    Bartha, J. L.
    Juan, M.
    Marti, A.
    Oros, D.
    Rodriguez, A.
    Scazzocchio, E.
    Olivares, J. M.
    Varea, S.
    Rios, J.
    Gratacos, E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (12) : 1990 - 1999
  • [38] Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder
    Kemp, David E.
    Gao, Keming
    Fein, Elizabeth B.
    Chan, Philip K.
    Conroy, Carla
    Obral, Sarah
    Ganocy, Stephen J.
    Calabrese, Joseph R.
    BIPOLAR DISORDERS, 2012, 14 (07) : 780 - 789
  • [39] Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial
    Wang, XuYi
    Jiang, Haifeng
    Zhao, Min
    Li, Jing
    Gray, Frank
    Sheng, Lixia
    Li, Yi
    Li, Xiaodong
    Ling, Walter
    Li, Wei
    Hao, Wei
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (01)
  • [40] Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania
    Vieta, Eduard
    Sachs, Gary
    Chang, Denise
    Hellsten, Johan
    Brewer, Claudette
    Peters-Strickland, Timothy
    Hefting, Nanco
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (08) : 971 - 982
12345